Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer
- 7 February 2015
- journal article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 22 (11), 3618-3624
- https://doi.org/10.1245/s10434-015-4422-6
Abstract
The prognosis of unresectable gastric cancer is poor. Chemotherapy occasionally converts an initially unresectable gastric cancer to a resectable cancer.This publication has 18 references indexed in Scilit:
- A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasisCancer Chemotherapy and Pharmacology, 2014
- Phase II multi-institutional prospective randomised trial comparing S-1+paclitaxel with S-1+cisplatin in patients with unresectable and/or recurrent advanced gastric cancerBritish Journal of Cancer, 2012
- Long-term follow up of patients who were positive for peritoneal lavage cytology: final report from the CCOG0301 studyGastric Cancer, 2012
- Induction Chemotherapy with S-1 Plus Cisplatin Followed by Surgery for Treatment of Gastric Cancer with Peritoneal DisseminationAnnals of Surgical Oncology, 2009
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trialThe Lancet Oncology, 2008
- Epidemiology of gastric cancerWorld Journal of Gastroenterology, 2006
- Randomized Phase III Trial of Fluorouracil Alone Versus Fluorouracil Plus Cisplatin Versus Uracil and Tegafur Plus Mitomycin in Patients With Unresectable, Advanced Gastric Cancer: The Japan Clinical Oncology Group Study (JCOG9205)Journal of Clinical Oncology, 2003
- Combined intensive chemotherapy and radical surgery for incurable gastric cancerAnnals of Surgical Oncology, 1997
- A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF)Annals of Oncology, 1994
- 5-Fluorouracil, Doxorubicin, and Mitomycin (FAM) Combination Chemotherapy for Advanced Gastric CancerAnnals of Internal Medicine, 1980